Tag: Blood cancer

First approved by the FDA in 2017 for mantle cell lymphoma, **calquence** (acalabrutinib) is a targeted oral medication used to treat certain B-cell malignancies. It is not a traditional chemotherapy drug but a Bruton's tyrosine kinase (BTK) inhibitor, a class of targeted therapies that work by interrupting specific signaling pathways within cancer cells. This targeted approach aims to limit the negative effects on healthy cells, offering a more precise treatment method.

According to its FDA approval, Bendeka is indicated for the treatment of two types of blood cancer: chronic lymphocytic leukemia (CLL) and a specific type of non-Hodgkin lymphoma (NHL). As an intravenous chemotherapy agent, Bendeka's purpose is to interfere with and kill cancer cells.

According to official product information and pharmaceutical databases, the pharmaceutical company **Roche** is the manufacturer of Ristova. This medication, with the generic name Rituximab, is a crucial therapy used for treating certain blood cancers and autoimmune disorders.

Arsenic trioxide, an inorganic compound with a long history in medicine, was approved by the FDA in 2000 under the brand name Trisenox® for the treatment of acute promyelocytic leukemia (APL). This once highly fatal blood cancer can now be managed with an ato injection, particularly when used in combination with other therapies.

Arsenic trioxide (ATO), also known by its brand name Trisenox, has transformed the prognosis for patients with a specific and aggressive type of blood cancer. A key component in modern cancer protocols, ATO is primarily used to treat Acute Promyelocytic Leukemia (APL) by targeting and destroying the specific leukemia cells.

As a potent and selective BCL-2 inhibitor, venetoclax represents a major advance in targeted cancer therapy, offering new treatment options for patients with specific blood cancers. In this comprehensive overview, we explore **what is venetoclax**, its mechanism, clinical applications, and key considerations for patients and healthcare providers.